Psychotropics India Ltd. is presently undergoing a transformation & developing itself into a very fast growing pharmaceutical company. With a team of 475 highly motivated employees it is going in the direction of a very strong medium size diversified organization. The present business model is very thoughtfully designed from its ethical division, followed by the newly launched generic division, then contract manufacturing for leading players of the country & export. The average growth rate for the last two years is more than twenty percent. Further the target for the next two years are planned at growth rate of twenty five percent each year, which the company is confident of achieving. The entry into Anti-biotics, Cosmetics and OTC products will give a strong boost into sales. With more than 550 authorised stockists in its operational area and contact with more than thirty thousand qualified doctors through its sales force, on a regular basis its going from strength to strength. The new facility for producing Beta Lactum products is now fully geared to make its mark in the Antibiotic market. The forth plant which is a state of the art has been commissioned in the month of March 2010. The total investment in this new plant is approx. 40 crores. This will improve the export business of company and bring it among the strong players in Medium Scale.